K.C. Pharmaceuticals Recalls Over 3 Million Eye Drop Bottles Due to Sterility Concerns

Wed, 08 Apr 2026 09:35:00 +0200

K.C. Pharmaceuticals, a California-based company, has recalled more than 3.1 million bottles of lubricating eye drops due to inadequate sterility testing, raising concerns about potential eye infections. The recall, initiated on March 3, 2026, affects eight products sold under multiple brand names at major U.S. retailers including Walgreens, CVS, Rite Aid, Kroger, and Dollar General. Lot numbers and expiration dates can be checked on the FDA website to confirm whether purchased products are affected. While no infections have been reported as of early April, consumers are advised to stop using recalled products and seek medical attention if they experience eye redness, discharge, swelling, or vision changes. This recall follows previous sterility issues at K.C. Pharmaceuticals and other manufacturers, highlighting persistent quality control problems in the eye drop market. The FDA has previously inspected over-the-counter eye drop manufacturers more frequently after outbreaks of severe